Researching Modifiable and Non-Modifiable Risk Factors Linked to Cognitive Resilience in Alzheimer’s Disease
What do we do?
Our lab focuses on clarifying how alterations in the brain and other biomolecules (such as cerebrospinal fluid β-amyloid) place some cognitively-normal individuals on a pernicious trajectory that culminates in Alzheimer’s dementia. In this context, we are particularly interested in discovering new knowledge concerning the modulation of the link between brain changes and cognitive decline by both modifiable (e.g., cognitively-stimulating activities, physical exercise) and non-modifiable (e.g., genetic vulnerability) factors. Overlaid on this research agenda are investigations of health accessibility, and how such accessibility exacerbates or ameliorates the impact of biomarkers on clinical phenotypes.
We use many techniques in our research, including but not limited to:
This is an accordion element with a series of buttons that open and close related content panels.
MRI and PET Imaging


Cerebrospinal Fluid Collection

Maximal Exercise Testing


Blood-based Biomarkers

Physical Activity Monitoring

Cognitive Testing

We are a part of the larger Wisconsin Alzheimer’s Disease Research Program, which includes both the Wisconsin Alzheimer’s Disease Research Center and the Wisconsin Alzheimer’s Institute.
Our offices are located on UW Madison’s campus within the UW Hospital and WARF. The majority of our research is conducted at the UW Hospital, the Waisman Center, the Wisconsin Institute for Medical Research, and the YMCA.
News Highlights

Ira Frahmand’s Abstract Accepted for Oral Presentation at AD/PD 2026
Ira’s abstract: “PROTEOMIC INSIGHT INTO ALZHEIMER’S DISEASE (AD)-RELEVANT PATHWAYS DISTINGUISHING KLOTHO KL-VS HETEROZYGOTES FROM NON-CARRIERS IN A SAMPLE AT RISK FOR AD” has been accepted for an Onsite Oral Presentation at AD/PD (International Conference on Alzheimer’s & …
October 23, 2025
Bri Breidenbach’s Abstract Accepted for Oral Presentation at AD/PD 2026
Bri’s abstract: “MULTIPLEXED PLASMA PROTEOMICS REVEAL DIVERGENT PROTEIN NETWORKS ASSOCIATED WITH RESISTANCE AND RESILIENCE TO ALZHEIMER’S DISEASE” has been accepted for an Onsite Oral Presentation at AD/PD (International Conference on Alzheimer’s & Parkinson’s Diseases), taking place from March …
October 23, 2025
Ikenna Odoh Passes Second Stage of US Medical License Examination
Ikenna Odoh passed the second stage of the US Medical License Examination this month! Congratulations on this accomplishment – we are so proud!
September 24, 2025
Ozioma Okonkwo Named Recipient of UAB Dept of Psychology Distinguished Scholar Alumni Award
Dr. Ozioma Okonkwo has been selected as the 2025 recipient of the University of Alabama at Birmingham (UAB) Department of Psychology Distinguished Scholar Alumni Award!! This award recognizes alumni of the Department for groundbreaking scientific …
September 5, 2025- More News
 





